Eliquis, Orencia sales propel Bristol-Myers to strong second quarter
Go back to Eliquis, Orencia sales propel Bristol-Myers to strong second quarter| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 54.00 -1.28 (2.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.28 | 52 Week High | $77.12 | |||
| Open | $55.20 | 52 Week Low | $49.03 | |||
| Day High | $55.33 | P/E | 35.06 | |||
| Day Low | $53.44 | EPS | $1.54 | |||
| Volume | 31,700,384 | |||||
| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 113.87 -1.57 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $115.44 | 52 Week High | $65.46 | |||
| Open | $114.64 | 52 Week Low | $47.97 | |||
| Day High | $114.94 | P/E | 77.46 | |||
| Day Low | $111.57 | EPS | $1.47 | |||
| Volume | 29,522,568 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.21 -0.71 (2.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.92 | 52 Week High | $37.39 | |||
| Open | $25.58 | 52 Week Low | $28.25 | |||
| Day High | $25.36 | P/E | 15.28 | |||
| Day Low | $24.94 | EPS | $1.65 | |||
| Volume | 119,614,341 | |||||
